Tel. +49 203 / 555858-31,-32,-33 · Fax: +49 203 / 35 82 99
21.01.2020
Genekam has developed novel corona virus 2020 (Wuhan strain specific) kits and potential therapeutic molecules.
21.01.2020
3D Genomemedicine Inc is going to operate in USA
Usually we are composed of 3 or 4 members coming from different scientific fields to create innovative solutions in the field of medicine. Here are experiences of some of our team members:
Member 1: Experience in virology, immunology and stem cells along with the field of management and marketing. Long experience in creating immunotherapies.
Member 2: Experience in Stemcells including cancer stem cells, fluorescent techniques like flow cytometry and molecular biology